News Tags :
cancer
vaccine
drug
blood
study
fda
cure
dendreon
prostate
aacr
men
therapy
researcher
research
hormone

Prostate Cancer Vaccines More Effective With Hormone Therapy

Prostate Cancer Vaccines More Effective With Hormone Therapy

   Among patients with castration-resistant prostate cancer, the addition of hormone therapy following vaccine treatment improved overall survival compared with either treatment alone or when the vaccine followed hormone treatment, according to recent data published in the July 15 Clinical Cancer Research, a journal of the American Association for Cancer Research.

Posted : Sun, Jul 13, 2008

Category : Science / Health News

New blood marker may predict prostate cancer spread

New blood marker may predict prostate cancer spread

   Information could lead to more accurate prediction of cancer metastasis thereby improving patient management.

Posted : Sun, Mar 02, 2008

Category : Science / Health News

African-American men and prostate cancer: Higher risk and understudied

African-American men and prostate cancer: Higher risk and understudied

   African-American men face a higher risk of developing prostate cancer in their lifetime, but researchers do not fully understand why.

Posted : Thu, Sep 06, 2007

Category : Science / Health News

FDA panel backs Dendreon's prostate cancer vaccine

FDA panel backs Dendreon's prostate cancer vaccine

   At a meeting held Thursday, Food and Drug Administration's (FDA) Office of Cellular, Tissue and Gene Therapies Advisory Committee said that there is substantial evidence of efficacy and safety of Dendreon Corp.'s Provenge (sipuleucel-T) for the treatment of patients with prostate cancer.

Posted : Sat, Mar 31, 2007

Category : Science / Health News
 
 
 
© TAUME.COM